XML 54 R39.htm IDEA: XBRL DOCUMENT v3.26.1
Other Income, Net (Tables)
 12 Months Ended
Mar. 31, 2026
Other Nonoperating Income (Expense) [Abstract]  
Schedule of Other Income, Net
Other income, net consists of the following:
Years Ended March 31,
(In millions)202620252024
Interest income (1)
$179 $173 $118 
Equity in earnings, net
7 9 4 
Net gains (losses) on investments in equity securities (2)
6 58 (24)
Other, net (3)
44 (38)34 
Total$236 $202 $132 
(1)The increase in interest income for fiscal 2026 compared to fiscal 2025 is primarily due to higher average intra‑period cash balances in fiscal 2026, driven by higher cash flows. The increase in fiscal 2025 compared to fiscal 2024 is primarily due to higher investable cash in fiscal 2025.
(2)Represents net realized and unrealized gains and losses as well as impairment charges on the Company’s investments in equity securities of certain U.S. growth stage companies in the healthcare industry. These net gains and losses primarily relate to mark-to-market adjustments for investments which are measured at fair value based on changes in the observable price of the securities and realized gains on the disposal of certain of these investments. For the year ended March 31, 2025, included net gains of $101 million related to investments in equity securities of certain U.S. growth stage companies in the healthcare industry, partially offset by a loss of $43 million related to an equity method investment. Refer to Financial Note 15, “Fair Value Measurements,” for more information on these types of investments.
(3)Other, net for all periods presented includes income recognized from finance charges to customers primarily for late fees. Other, net for the year ended March 31, 2025 includes charges of $87 million related to the termination of the U.K. pension plan. Refer to Financial Note 13, “Pension Benefits,” for more detail.